Nairobi,KENYA:Kenya has launched a new drug in bid to accelerate access of better anti-retro viral drugs for the people living with Hiv and Aids across the country.
The government in conjunction with the UNITIAD announced the introduction of the drug known as Dolutegravir DTG which has few side effects and easier to take .
The director of medical services Dr Jackson Kioko said that patients are less likely to develop resistance whenever they take the drug and it is a first line regimen for the adults and adolescents.
“We are delighted to partner with Unitaid on this innovative project that will no doubt improve lives of Kenyans livings with HIV and AIDS .”Said Dr Kioko
The ministry of health will provide the drug to 27,000 people living with HIV and Aids who are unable to tolerate the currenbt drug in various health facilities.
More than 18 million people are on life long HIV treatment worldwide ,but almost equal number do not have access to treatment yet.
In Kenya approximately 1.5 million people are living with HIV and Aids and over one million are currently on ARVS.